SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-001005
Filing Date
2019-09-03
Accepted
2019-09-03 16:15:07
Documents
14
Period of Report
2019-09-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv528776_8k.htm   iXBRL 8-K 24747
2 EXHIBIT 99.1 tv528776_ex99-1.htm EX-99.1 15373
3 GRAPHIC tv528776_ex99-1img01.jpg GRAPHIC 18568
  Complete submission text file 0001410578-19-001005.txt   237991

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA qure-20190903.xsd EX-101.SCH 3184
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE qure-20190903_lab.xml EX-101.LAB 33476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qure-20190903_pre.xml EX-101.PRE 21957
16 EXTRACTED XBRL INSTANCE DOCUMENT tv528776_8k_htm.xml XML 3319
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 191072283
SIC: 2834 Pharmaceutical Preparations